Scleroderma Treatment in Turkey | Specialist Care, Therapies & Prices

Understanding scleroderma: what is it?

Scleroderma is a rare chronic autoimmune disease. The body's immune system starts producing too much collagen, which gradually hardens the skin and can damage internal organs. It's not contagious or hereditary in the traditional sense, and for many patients, the diagnosis comes as a shock.

Two people with scleroderma can have very different experiences. One might deal mainly with skin tightness. Another might face lung or kidney complications. That's why treatment is never one-size-fits-all.

Localized vs. systemic scleroderma: What's the difference?

Understanding which form you have is the starting point for everything; it determines the specialists involved, the treatments prescribed, and the monitoring needed over time. These two forms share the same name but follow very different paths.

Whether your diagnosis is localized or systemic, one thing remains true: the earlier a structured treatment plan is in place, the better the chances of slowing progression and protecting your quality of life.

What causes scleroderma?

The exact trigger remains unknown. What specialists have identified are several factors that, alone or combined, seem to set the disease in motion.

Genetic predisposition

Some people carry immune-related genes that make them more reactive to certain triggers. This doesn't mean scleroderma is inherited, but a favorable genetic background can tip the balance toward an abnormal immune response.

Immune system dysfunction

The immune system mistakenly attacks healthy connective tissue, causing chronic inflammation and excessive collagen production. That excess collagen is what drives the skin thickening and organ damage characteristic of the disease.

Hormonal factors

Scleroderma disproportionately affects women between 30 and 50. Estrogen is suspected of playing a role in modulating immune activity, though the exact mechanism is still being studied.

Environmental exposures

Prolonged contact with silica dust, organic solvents, heavy metals, or certain viruses may act as a trigger in genetically predisposed individuals, setting off an uncontrolled immune response.

Recognizing the symptoms

Scleroderma doesn't announce itself the same way twice. Some people notice their fingers changing color in winter and brush it off for years. Others wake up one day unable to fully close their hand. The symptoms depend heavily on which form you have and how far things have progressed.

The most common signs to watch for:

• Skin tightening and thickening: especially on the hands and face, where everyday movements start to feel restricted
• Raynaud's phenomenon: fingers turn white or bluish in the cold, often the very first symptom to appear
• Joint and muscle pain: stiffness that makes gripping, bending, or climbing stairs increasingly difficult
• Persistent fatigue: the kind that a good night's sleep doesn't fix
• Digestive problems: acid reflux, bloating, difficulty swallowing; the gut is often affected earlier than people realize
• Shortness of breath: when the lungs are involved, even mild exertion can become uncomfortable

None of these symptoms should be waited out. The earlier a specialist puts a name to what's happening, the more tools are available to slow it down.

Drug treatments of scleroderma used in Turkey

Turkish specialist centers tailor pharmacological treatment to each patient's profile, disease form, and current organ involvement.

For skin and joint symptoms:

• NSAIDs for pain and inflammation.
• Low-dose corticosteroids in flare-ups.
• Methotrexate, commonly used for skin involvement, especially in diffuse systemic forms.

For immune modulation:

• Cyclophosphamide, indicated in lung or kidney involvement.
• Mycophenolate mofetil, an alternative immunosuppressant with a better long-term tolerance profile.
• Hydroxychloroquine, used for fatigue and musculoskeletal symptoms

For severe or resistant cases:

• Tocilizumab (IL-6 receptor blocker),approved for skin involvement in systemic sclerosis
• Rituximab (anti-CD20 biotherapy),used in patients who don't respond to conventional immunosuppressants

Each protocol is adjusted over time by a team that typically includes a rheumatologist, dermatologist, pulmonologist, and internist working together.

Managing organ-specific complications

In systemic scleroderma, the skin is rarely the only concern. As the disease progresses, it can reach the lungs, kidneys, vessels, and gut, each requiring its own treatment approach.

Vascular & Raynaud's phenomenon

Vasodilators such as calcium channel blockers, iloprost infusions, bosentan, and sildenafil are used to manage Raynaud's episodes and prevent digital ulcers, a frequent and painful complication.

Pulmonary involvement

Pulmonary fibrosis and pulmonary arterial hypertension are serious risks in systemic scleroderma. Treatment in Istanbul hospitals includes:

• Regular high-resolution CT scans and pulmonary function tests.
• Antifibrotic agents such as nintedanib.
• Oxygen therapy when needed.
• Pulmonary hypertension-specific treatments (phosphodiesterase inhibitors, endothelin receptor antagonists).

Gastrointestinal involvement

Acid reflux is almost universal in systemic scleroderma. Proton pump inhibitors are the standard first step. For more severe gut motility issues, prokinetics and nutritional support are recommended. Sometimes enteral nutrition is added.

Renal crisis

Scleroderma renal crisis is a medical emergency. It requires rapid intervention with ACE inhibitors and close nephrological monitoring. Turkish tertiary hospitals are equipped to manage this with intensive care protocols.

Rehabilitation and supportive care

Medication controls the disease. But it's everything around it that helps you actually live with it.

• Physiotherapy: keeps joints mobile and prevents the skin contractions that slowly limit movement
• Occupational therapy: focuses on the hands, where scleroderma hits hardest in daily life
• Psychological support: a chronic autoimmune diagnosis changes more than just your body; having someone to talk to matters
• Nutritional follow-up: adapted to whatever digestive symptoms you're dealing with, which vary a lot from one patient to the next
• Skin care and aesthetic treatments: for scarring, dryness, and hyperpigmentation that affect how patients feel about themselves

Long-term follow-up: What happens after treatment?

This is the section most patients don't hear enough about before they travel.

Scleroderma requires lifelong monitoring, not just acute treatment. After the initial care protocol in Turkey, a structured follow-up plan is put in place:

Every 3–6 months (typical schedule):

• Clinical evaluation of skin involvement and joint function
• Blood tests: inflammatory markers, kidney function, complete blood count
• Review of current medications and tolerance

Every 6–12 months:

• Pulmonary function tests (spirometry, DLCO)
• High-resolution chest CT if respiratory symptoms change
• Cardiac echography to screen for pulmonary hypertension
• Upper GI assessment if digestive symptoms worsen

Flare management:
When disease activity increases, immunosuppressants may be temporarily escalated, additional biotherapy cycles considered, or organ-specific specialists brought in for reassessment.

Turquie Santé coordinates remote follow-up directly with your local physician after your return home, including a full translated medical report from your treating team.